CN Stock MarketDetailed Quotes

300357 Zhejiang Wolwo Bio-Pharmaceutical

Watchlist
  • 21.66
  • +0.12+0.56%
Market Closed Dec 20 15:00 CST
11.34BMarket Cap36.34P/E (TTM)

Zhejiang Wolwo Bio-Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
1.79%1.09B
3.45%1.22B
29.86%1.2B
39.34%1.17B
36.41%1.07B
58.01%1.18B
27.41%920.42M
29.34%840.69M
26.65%782.49M
8.32%748.29M
Transactional financial assets
41.76%165.12M
3.35%94.92M
-62.33%87.79M
-60.22%117.39M
-61.04%116.48M
-70.24%91.84M
-28.89%233.07M
-20.46%295.05M
-4.32%298.97M
46.25%308.61M
Notes receivable and accounts receivable
-10.42%247.44M
-8.85%198.9M
-11.70%188.03M
-36.46%161.58M
-5.34%276.22M
-2.00%218.21M
-5.51%212.95M
6.80%254.31M
8.08%291.8M
9.44%222.67M
-Notes receivable
-68.44%17.6M
-73.78%13.71M
-73.66%11.78M
-77.62%18.62M
-11.22%55.76M
-4.65%52.29M
-23.40%44.71M
1.46%83.21M
7.54%62.81M
46.65%54.84M
-Accounts receivable
4.26%229.84M
11.61%185.19M
4.76%176.26M
-16.45%142.96M
-3.73%220.46M
-1.14%165.92M
0.74%168.25M
9.60%171.1M
8.23%228.99M
1.06%167.83M
Other receivables (including interest and dividends)
-62.69%8.01M
-61.37%7.96M
-68.71%7.2M
-68.72%6.2M
27.69%21.47M
29.26%20.6M
81.09%23.01M
77.99%19.81M
21.01%16.81M
28.53%15.93M
-Other receivable
----
-61.37%7.96M
----
----
----
29.26%20.6M
----
77.99%19.81M
----
28.53%15.93M
Advance payment
-53.80%5.27M
-58.24%4.96M
-70.93%5.34M
-46.07%5.82M
11.65%11.41M
-4.47%11.88M
83.16%18.38M
56.04%10.79M
15.29%10.22M
61.28%12.43M
Inventories
-5.19%52.51M
16.21%61.76M
18.74%60.09M
21.95%59.04M
17.13%55.39M
6.30%53.14M
4.37%50.61M
-9.94%48.41M
-8.08%47.29M
-2.35%49.99M
Receivable financing
--68.71M
--42.79M
--39.17M
--41.34M
----
----
----
----
----
----
Other current assets
-2.47%15.33M
17.30%13.82M
127.17%12.78M
-11.30%7.16M
461.82%15.72M
171.64%11.78M
-58.38%5.62M
-24.34%8.07M
-74.65%2.8M
-71.59%4.34M
Total current assets
5.42%1.65B
3.67%1.65B
8.99%1.6B
6.28%1.57B
7.84%1.56B
16.70%1.59B
7.63%1.46B
10.11%1.48B
12.82%1.45B
14.30%1.36B
Non Current assets
Other equity investment
--5.43M
--5.43M
--5.4M
----
----
----
----
----
----
----
Investment real estate
----
----
----
----
--10.82M
----
----
----
----
----
Long-term equity investment
-2.45%72.77M
-4.38%73.11M
-5.01%73.72M
-5.34%74.21M
-7.68%74.6M
-6.96%76.46M
-6.54%77.61M
-5.94%78.4M
-4.98%80.8M
--82.18M
Fixed assets
----
129.05%450.29M
----
----
----
32.60%196.59M
----
32.20%201.9M
----
-5.49%148.26M
Constru in process
----
-23.65%275.02M
----
----
----
105.13%360.2M
----
61.22%226.24M
----
74.19%175.6M
Intangible assets
-7.46%152.25M
-7.57%154.87M
14.98%158.17M
15.55%161.38M
15.82%164.52M
53.32%167.56M
23.39%137.57M
48.58%139.67M
47.77%142.04M
11.24%109.29M
Development expenditure
25.10%30.66M
40.20%29.01M
-46.95%28.1M
-45.74%27.04M
-72.81%24.51M
-76.34%20.69M
-38.03%52.98M
-39.49%49.83M
16.61%90.15M
17.70%87.46M
Long deferred expense
-5.99%6.61M
16.73%6.92M
49.74%6.89M
117.91%7.34M
124.69%7.03M
94.76%5.93M
49.69%4.6M
-8.87%3.37M
0.30%3.13M
-15.16%3.04M
Deferred tax assets
7.03%6.5M
9.09%5.95M
7.09%5.23M
3.34%5.03M
-8.16%6.07M
-5.47%5.45M
-17.29%4.89M
-16.13%4.87M
2.04%6.61M
-2.88%5.77M
Usufruct assets
-40.59%13.85M
38.91%25M
35.96%26.81M
72.35%28.37M
27.75%23.3M
230.35%17.99M
196.06%19.72M
92.40%16.46M
157.96%18.24M
-31.02%5.45M
Other non current assets
--4.39M
--7.79M
--13.01M
--12.42M
----
----
----
----
----
----
Total non current assets
11.15%1.05B
21.45%1.03B
29.59%1.03B
37.67%992.27M
35.95%946.59M
37.90%850.88M
29.69%793.66M
22.07%720.74M
22.56%696.27M
28.24%617.04M
Total assets
7.58%2.7B
9.87%2.68B
16.23%2.62B
16.57%2.56B
16.96%2.51B
23.31%2.44B
14.47%2.26B
13.76%2.2B
15.81%2.15B
18.31%1.98B
Liabilities
Current liabilities
Short term loan
153.75%37.22M
62.31%44.37M
145.87%49.17M
--34.39M
--14.67M
--27.33M
--20M
----
----
----
Notes payable and accounts payable
5.63%8.17M
16.88%7.55M
39.37%7.49M
4.03%7.99M
-10.32%7.73M
-24.05%6.46M
4.69%5.37M
51.09%7.68M
69.48%8.62M
43.66%8.51M
-Accounts payable
5.63%8.17M
16.88%7.55M
39.37%7.49M
4.03%7.99M
-10.32%7.73M
-24.05%6.46M
4.69%5.37M
51.09%7.68M
69.48%8.62M
43.66%8.51M
Contract liabilities
511.61%1.38M
322.80%1.42M
446.92%1.5M
-8.21%384.28K
-32.89%226.28K
-77.57%336.46K
-58.45%273.72K
0.28%418.64K
13.00%337.16K
369.57%1.5M
Salaries payable
-5.66%24.22M
4.04%19.79M
3.41%19.75M
9.77%29.04M
3.33%25.67M
6.53%19.02M
10.77%19.1M
11.61%26.45M
22.08%24.85M
8.93%17.85M
Taxs payable
1.00%30.08M
-8.83%17.05M
11.44%19.03M
-52.16%14.5M
1.25%29.78M
-47.43%18.7M
-28.11%17.08M
-51.83%30.31M
-40.14%29.41M
103.67%35.58M
Other payable (including interest and dividends)
-30.62%57.19M
7.07%151.62M
118.01%57.76M
147.58%83.94M
182.73%82.43M
709.10%141.61M
235.36%26.5M
238.89%33.9M
181.17%29.15M
25.86%17.5M
-Dividend payable
----
-7.50%96.86M
----
----
----
--104.72M
----
----
----
----
-Other payable
----
48.41%54.76M
----
----
----
110.81%36.9M
----
238.89%33.9M
----
25.86%17.5M
Non current liabilities due within one year
-31.68%5.14M
41.74%6.83M
28.69%7.21M
70.73%6.8M
25.13%7.53M
-6.40%4.82M
14.39%5.6M
-32.07%3.98M
32.05%6.01M
17.61%5.15M
Total current liabilities
-2.76%163.39M
13.90%248.64M
72.39%161.92M
72.30%177.04M
70.79%168.03M
153.56%218.29M
57.62%93.92M
-4.86%102.75M
9.56%98.38M
47.45%86.09M
Current liabilities
Deferred tax liabilities
-28.58%177.8K
10.83%176.74K
126.76%202.25K
158.41%203.24K
-59.14%248.96K
-62.28%159.46K
-89.24%89.19K
-84.23%78.65K
-91.40%609.31K
176.33%422.71K
Long term deferred income
8.51%33.97M
8.93%34.41M
11.67%30.49M
12.77%30.93M
27.52%31.31M
28.05%31.59M
10.14%27.31M
10.09%27.43M
-1.94%24.55M
-1.93%24.67M
Lease liabilities
-44.12%8.37M
40.76%17.75M
38.07%19.53M
73.06%21.26M
17.03%14.97M
2,413.15%12.61M
853.77%14.14M
530.86%12.28M
627.14%12.79M
-82.29%501.72K
Other non current liabilities
-8.58%25.8M
-8.58%25.8M
2.87%29.03M
2.87%29.03M
--28.22M
--28.22M
--28.22M
--28.22M
----
----
Total non current liabilities
-8.61%68.31M
7.65%78.13M
13.61%79.25M
19.72%81.42M
96.95%74.75M
183.56%72.58M
157.37%69.76M
148.57%68.01M
12.03%37.95M
-9.05%25.6M
Total liabilities
-4.56%231.71M
12.34%326.77M
47.34%241.17M
51.36%258.46M
78.08%242.77M
160.43%290.87M
88.81%163.68M
26.16%170.76M
10.24%136.33M
29.08%111.69M
Shareholders equity
Paid-in capital
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
0.00%523.58M
Capital reserve funds
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
0.00%128.19M
Surplus reserve funds
15.14%270.72M
15.14%270.72M
15.14%270.72M
15.14%270.72M
20.79%235.12M
20.79%235.12M
20.79%235.12M
20.79%235.12M
24.97%194.65M
24.97%194.65M
Retained profit
14.30%1.44B
15.70%1.31B
15.19%1.34B
15.55%1.26B
13.17%1.26B
17.71%1.14B
18.52%1.16B
22.83%1.09B
29.49%1.11B
35.78%965.48M
Other composite income
-15.05%29.43K
14,878.63%5.41M
26,045.83%5.38M
16.29%30.85K
14.85%34.64K
170.46%36.09K
1,275.44%20.57K
5,183.97%26.53K
412.14%30.16K
-98.46%13.34K
Shareholders equity without minority interests
10.05%2.36B
10.84%2.24B
10.62%2.27B
10.38%2.19B
9.55%2.14B
11.67%2.02B
12.16%2.05B
14.03%1.98B
17.53%1.96B
19.25%1.81B
Minority interests
-11.43%108.85M
-11.38%112M
161.90%115.32M
149.76%118.61M
135.28%122.9M
126.90%126.38M
-23.78%44.03M
-21.55%47.49M
-18.30%52.24M
-16.89%55.7M
Total shareholder equity
8.88%2.47B
9.54%2.35B
13.80%2.38B
13.64%2.3B
12.81%2.27B
15.11%2.15B
11.06%2.09B
12.83%2.03B
16.21%2.01B
17.72%1.87B
Total liabilityies and equity
7.58%2.7B
9.87%2.68B
16.23%2.62B
16.57%2.56B
16.96%2.51B
23.31%2.44B
14.47%2.26B
13.76%2.2B
15.81%2.15B
18.31%1.98B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young Huaming Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 1.79%1.09B3.45%1.22B29.86%1.2B39.34%1.17B36.41%1.07B58.01%1.18B27.41%920.42M29.34%840.69M26.65%782.49M8.32%748.29M
Transactional financial assets 41.76%165.12M3.35%94.92M-62.33%87.79M-60.22%117.39M-61.04%116.48M-70.24%91.84M-28.89%233.07M-20.46%295.05M-4.32%298.97M46.25%308.61M
Notes receivable and accounts receivable -10.42%247.44M-8.85%198.9M-11.70%188.03M-36.46%161.58M-5.34%276.22M-2.00%218.21M-5.51%212.95M6.80%254.31M8.08%291.8M9.44%222.67M
-Notes receivable -68.44%17.6M-73.78%13.71M-73.66%11.78M-77.62%18.62M-11.22%55.76M-4.65%52.29M-23.40%44.71M1.46%83.21M7.54%62.81M46.65%54.84M
-Accounts receivable 4.26%229.84M11.61%185.19M4.76%176.26M-16.45%142.96M-3.73%220.46M-1.14%165.92M0.74%168.25M9.60%171.1M8.23%228.99M1.06%167.83M
Other receivables (including interest and dividends) -62.69%8.01M-61.37%7.96M-68.71%7.2M-68.72%6.2M27.69%21.47M29.26%20.6M81.09%23.01M77.99%19.81M21.01%16.81M28.53%15.93M
-Other receivable -----61.37%7.96M------------29.26%20.6M----77.99%19.81M----28.53%15.93M
Advance payment -53.80%5.27M-58.24%4.96M-70.93%5.34M-46.07%5.82M11.65%11.41M-4.47%11.88M83.16%18.38M56.04%10.79M15.29%10.22M61.28%12.43M
Inventories -5.19%52.51M16.21%61.76M18.74%60.09M21.95%59.04M17.13%55.39M6.30%53.14M4.37%50.61M-9.94%48.41M-8.08%47.29M-2.35%49.99M
Receivable financing --68.71M--42.79M--39.17M--41.34M------------------------
Other current assets -2.47%15.33M17.30%13.82M127.17%12.78M-11.30%7.16M461.82%15.72M171.64%11.78M-58.38%5.62M-24.34%8.07M-74.65%2.8M-71.59%4.34M
Total current assets 5.42%1.65B3.67%1.65B8.99%1.6B6.28%1.57B7.84%1.56B16.70%1.59B7.63%1.46B10.11%1.48B12.82%1.45B14.30%1.36B
Non Current assets
Other equity investment --5.43M--5.43M--5.4M----------------------------
Investment real estate ------------------10.82M--------------------
Long-term equity investment -2.45%72.77M-4.38%73.11M-5.01%73.72M-5.34%74.21M-7.68%74.6M-6.96%76.46M-6.54%77.61M-5.94%78.4M-4.98%80.8M--82.18M
Fixed assets ----129.05%450.29M------------32.60%196.59M----32.20%201.9M-----5.49%148.26M
Constru in process -----23.65%275.02M------------105.13%360.2M----61.22%226.24M----74.19%175.6M
Intangible assets -7.46%152.25M-7.57%154.87M14.98%158.17M15.55%161.38M15.82%164.52M53.32%167.56M23.39%137.57M48.58%139.67M47.77%142.04M11.24%109.29M
Development expenditure 25.10%30.66M40.20%29.01M-46.95%28.1M-45.74%27.04M-72.81%24.51M-76.34%20.69M-38.03%52.98M-39.49%49.83M16.61%90.15M17.70%87.46M
Long deferred expense -5.99%6.61M16.73%6.92M49.74%6.89M117.91%7.34M124.69%7.03M94.76%5.93M49.69%4.6M-8.87%3.37M0.30%3.13M-15.16%3.04M
Deferred tax assets 7.03%6.5M9.09%5.95M7.09%5.23M3.34%5.03M-8.16%6.07M-5.47%5.45M-17.29%4.89M-16.13%4.87M2.04%6.61M-2.88%5.77M
Usufruct assets -40.59%13.85M38.91%25M35.96%26.81M72.35%28.37M27.75%23.3M230.35%17.99M196.06%19.72M92.40%16.46M157.96%18.24M-31.02%5.45M
Other non current assets --4.39M--7.79M--13.01M--12.42M------------------------
Total non current assets 11.15%1.05B21.45%1.03B29.59%1.03B37.67%992.27M35.95%946.59M37.90%850.88M29.69%793.66M22.07%720.74M22.56%696.27M28.24%617.04M
Total assets 7.58%2.7B9.87%2.68B16.23%2.62B16.57%2.56B16.96%2.51B23.31%2.44B14.47%2.26B13.76%2.2B15.81%2.15B18.31%1.98B
Liabilities
Current liabilities
Short term loan 153.75%37.22M62.31%44.37M145.87%49.17M--34.39M--14.67M--27.33M--20M------------
Notes payable and accounts payable 5.63%8.17M16.88%7.55M39.37%7.49M4.03%7.99M-10.32%7.73M-24.05%6.46M4.69%5.37M51.09%7.68M69.48%8.62M43.66%8.51M
-Accounts payable 5.63%8.17M16.88%7.55M39.37%7.49M4.03%7.99M-10.32%7.73M-24.05%6.46M4.69%5.37M51.09%7.68M69.48%8.62M43.66%8.51M
Contract liabilities 511.61%1.38M322.80%1.42M446.92%1.5M-8.21%384.28K-32.89%226.28K-77.57%336.46K-58.45%273.72K0.28%418.64K13.00%337.16K369.57%1.5M
Salaries payable -5.66%24.22M4.04%19.79M3.41%19.75M9.77%29.04M3.33%25.67M6.53%19.02M10.77%19.1M11.61%26.45M22.08%24.85M8.93%17.85M
Taxs payable 1.00%30.08M-8.83%17.05M11.44%19.03M-52.16%14.5M1.25%29.78M-47.43%18.7M-28.11%17.08M-51.83%30.31M-40.14%29.41M103.67%35.58M
Other payable (including interest and dividends) -30.62%57.19M7.07%151.62M118.01%57.76M147.58%83.94M182.73%82.43M709.10%141.61M235.36%26.5M238.89%33.9M181.17%29.15M25.86%17.5M
-Dividend payable -----7.50%96.86M--------------104.72M----------------
-Other payable ----48.41%54.76M------------110.81%36.9M----238.89%33.9M----25.86%17.5M
Non current liabilities due within one year -31.68%5.14M41.74%6.83M28.69%7.21M70.73%6.8M25.13%7.53M-6.40%4.82M14.39%5.6M-32.07%3.98M32.05%6.01M17.61%5.15M
Total current liabilities -2.76%163.39M13.90%248.64M72.39%161.92M72.30%177.04M70.79%168.03M153.56%218.29M57.62%93.92M-4.86%102.75M9.56%98.38M47.45%86.09M
Current liabilities
Deferred tax liabilities -28.58%177.8K10.83%176.74K126.76%202.25K158.41%203.24K-59.14%248.96K-62.28%159.46K-89.24%89.19K-84.23%78.65K-91.40%609.31K176.33%422.71K
Long term deferred income 8.51%33.97M8.93%34.41M11.67%30.49M12.77%30.93M27.52%31.31M28.05%31.59M10.14%27.31M10.09%27.43M-1.94%24.55M-1.93%24.67M
Lease liabilities -44.12%8.37M40.76%17.75M38.07%19.53M73.06%21.26M17.03%14.97M2,413.15%12.61M853.77%14.14M530.86%12.28M627.14%12.79M-82.29%501.72K
Other non current liabilities -8.58%25.8M-8.58%25.8M2.87%29.03M2.87%29.03M--28.22M--28.22M--28.22M--28.22M--------
Total non current liabilities -8.61%68.31M7.65%78.13M13.61%79.25M19.72%81.42M96.95%74.75M183.56%72.58M157.37%69.76M148.57%68.01M12.03%37.95M-9.05%25.6M
Total liabilities -4.56%231.71M12.34%326.77M47.34%241.17M51.36%258.46M78.08%242.77M160.43%290.87M88.81%163.68M26.16%170.76M10.24%136.33M29.08%111.69M
Shareholders equity
Paid-in capital 0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M0.00%523.58M
Capital reserve funds 0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M0.00%128.19M
Surplus reserve funds 15.14%270.72M15.14%270.72M15.14%270.72M15.14%270.72M20.79%235.12M20.79%235.12M20.79%235.12M20.79%235.12M24.97%194.65M24.97%194.65M
Retained profit 14.30%1.44B15.70%1.31B15.19%1.34B15.55%1.26B13.17%1.26B17.71%1.14B18.52%1.16B22.83%1.09B29.49%1.11B35.78%965.48M
Other composite income -15.05%29.43K14,878.63%5.41M26,045.83%5.38M16.29%30.85K14.85%34.64K170.46%36.09K1,275.44%20.57K5,183.97%26.53K412.14%30.16K-98.46%13.34K
Shareholders equity without minority interests 10.05%2.36B10.84%2.24B10.62%2.27B10.38%2.19B9.55%2.14B11.67%2.02B12.16%2.05B14.03%1.98B17.53%1.96B19.25%1.81B
Minority interests -11.43%108.85M-11.38%112M161.90%115.32M149.76%118.61M135.28%122.9M126.90%126.38M-23.78%44.03M-21.55%47.49M-18.30%52.24M-16.89%55.7M
Total shareholder equity 8.88%2.47B9.54%2.35B13.80%2.38B13.64%2.3B12.81%2.27B15.11%2.15B11.06%2.09B12.83%2.03B16.21%2.01B17.72%1.87B
Total liabilityies and equity 7.58%2.7B9.87%2.68B16.23%2.62B16.57%2.56B16.96%2.51B23.31%2.44B14.47%2.26B13.76%2.2B15.81%2.15B18.31%1.98B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)------Ernst & Young Huaming Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Specialized, Special and New
Specialized, Special and New
Intraday+2.45%
AI
AI
Intraday+1.18%
Cosmetics Concept
Cosmetics Concept
Intraday+0.97%